1. Home
  2. AADI vs MODD Comparison

AADI vs MODD Comparison

Compare AADI & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • MODD
  • Stock Information
  • Founded
  • AADI 2011
  • MODD 1998
  • Country
  • AADI United States
  • MODD United States
  • Employees
  • AADI N/A
  • MODD N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • MODD Industrial Specialties
  • Sector
  • AADI Health Care
  • MODD Health Care
  • Exchange
  • AADI Nasdaq
  • MODD Nasdaq
  • Market Cap
  • AADI 59.4M
  • MODD 53.0M
  • IPO Year
  • AADI N/A
  • MODD N/A
  • Fundamental
  • Price
  • AADI $2.98
  • MODD $1.21
  • Analyst Decision
  • AADI Hold
  • MODD Buy
  • Analyst Count
  • AADI 3
  • MODD 1
  • Target Price
  • AADI $1.75
  • MODD $5.00
  • AVG Volume (30 Days)
  • AADI 863.3K
  • MODD 152.4K
  • Earning Date
  • AADI 03-12-2025
  • MODD 02-11-2025
  • Dividend Yield
  • AADI N/A
  • MODD N/A
  • EPS Growth
  • AADI N/A
  • MODD N/A
  • EPS
  • AADI N/A
  • MODD N/A
  • Revenue
  • AADI $25,070,000.00
  • MODD N/A
  • Revenue This Year
  • AADI $8.43
  • MODD N/A
  • Revenue Next Year
  • AADI $5.41
  • MODD $862.50
  • P/E Ratio
  • AADI N/A
  • MODD N/A
  • Revenue Growth
  • AADI 7.80
  • MODD N/A
  • 52 Week Low
  • AADI $1.21
  • MODD $1.08
  • 52 Week High
  • AADI $3.81
  • MODD $2.65
  • Technical
  • Relative Strength Index (RSI)
  • AADI 50.12
  • MODD 30.05
  • Support Level
  • AADI $2.91
  • MODD $1.36
  • Resistance Level
  • AADI $3.27
  • MODD $1.34
  • Average True Range (ATR)
  • AADI 0.27
  • MODD 0.09
  • MACD
  • AADI -0.06
  • MODD -0.00
  • Stochastic Oscillator
  • AADI 11.68
  • MODD 15.20

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: